WeightWatchers built its name on points and group support, but the weight-loss conversation has moved to GLP-1 medications. So can you actually get a GLP-1 through WeightWatchers, is it trustworthy, and how does it stack up against Hims, Hers, and Noom? Here is the straight answer.
Quick answer: Yes, WeightWatchers offers GLP-1 medications through a clinical telehealth arm, where affiliated clinicians can prescribe drugs like semaglutide and tirzepatide to eligible members. It pairs medication with WW's behavioral coaching, which is its main differentiator. It is a legitimate program, but it is membership-based, medication and pricing change, and you still need to qualify medically. Competing telehealth services (Hims, Hers, Noom) offer similar GLP-1 access with different pricing and coaching styles. As of September 5, 2026, WW's Med+ membership is $25 a month for the first two months on a 12-month plan and then $74 a month, with medication billed separately, and WW prescribes FDA-approved brands only.
Can you get a GLP-1 from WeightWatchers?
Yes. WeightWatchers operates a clinical program in which licensed clinicians evaluate members and can prescribe GLP-1 medications when appropriate. The pitch is that you get the medication plus WW's long-running behavioral system, food tracking, coaching, and community, which is the piece pure telehealth pill-mills tend to skip. You must qualify based on BMI and health history, the same medical gatekeeping any responsible provider applies.
As of September 5, 2026, WW prescribes FDA-approved brand medications only: Wegovy (injection and pill), Zepbound, Saxenda, the Foundayo pill, metformin and naltrexone/bupropion, filled through its mail-order partner Carepoint in Schaumburg, Illinois. No compounded GLP-1 appears on any WW page; third-party reviewers date WW's exit from compounded semaglutide to May 2025, after the FDA declared the tirzepatide shortage resolved (December 19, 2024) and the semaglutide shortage resolved (February 21, 2025). For cash-pay Zepbound, WW routes members to LillyDirect vials and KwikPens at $299, $399 or $449 a month. Menus and prices change, so confirm current details directly with WW before enrolling.
Is WeightWatchers GLP-1 safe and trustworthy?
It is a real medical program, not a gray-market seller. Prescriptions come from licensed clinicians, and medications are dispensed through pharmacies. That makes it trustworthy in the ways that matter most: licensed oversight, a prescription requirement, and screening before treatment. The legitimate cautions are practical rather than safety alarms, you are paying an ongoing membership, the program can require lab work or check-ins, and what is covered by your insurance varies widely. Read the cancellation terms before you start.
WeightWatchers GLP-1 reviews: what members say
The numbers that exist as of September 2026: WW reports an average 21% body-weight loss at 12 months among Med+ members on a GLP-1 (company data from about 3,250 patients, not peer reviewed) and says more than 70% of surveyed Med+ members feel the program helps minimize side effects (WW release, December 16, 2025). Third-party aggregators put WW's Trustpilot score at about 3.9 out of 5 across more than 1,660 reviews. For context, the Zepbound label reports 20.9% mean weight loss at 72 weeks on the 15 mg dose in SURMOUNT-1, so WW's figure sits where the drug itself sits. Beyond that, member feedback clusters around a few themes. People who value structure like that the medication arrives wrapped in WW's coaching and tracking, which can help with the muscle-preservation and protein habits that make GLP-1 results stick. Common complaints mirror all subscription health services: billing that is easy to start and harder to stop, variable wait times, and frustration when a desired medication is not available or not covered. As with any telehealth review, weigh patterns over single anecdotes.
Not sure which GLP-1 is right for you?
Take a 2-minute assessment and get a personalized recommendation after licensed provider review.
Take the Assessment →GLP-1 weight-loss programs compared
| Program | GLP-1 access | Coaching style | Best for |
|---|---|---|---|
| WeightWatchers | Brand GLP-1s only (Wegovy, Zepbound, Saxenda, Foundayo) plus WW behavioral program; $74 a month after a $25 introductory rate (September 2026) | Points system, food tracking, community | People who want medication plus a structured lifestyle system |
| Hims / Hers | Brand GLP-1s (Wegovy pill and pen, Zepbound); a July 2026 third-party review reports compounded semaglutide closed to new patients in March 2026, and hims.com was not readable for this update | App-based, lighter touch | Streamlined, mostly self-directed users |
| Noom (Noom Med) | Brand-medication telehealth ($39 then $129 a month) plus compounded semaglutide, microdose and tirzepatide tracks ($79 to $149 first month, then $179 to $299) | Psychology-based behavior change | People who want habit and mindset coaching |
Medication availability, compounded vs branded options, and pricing change frequently across all three. Verify current terms on each company's site.
Hims vs WeightWatchers and Hers vs WeightWatchers
The core trade-off is coaching depth versus simplicity. Hims and Hers are built around a fast, app-first experience and generally lighter behavioral support. WeightWatchers leans on decades of behavior-change infrastructure, which can matter because GLP-1 results depend heavily on diet quality, protein intake, and resistance training to limit muscle loss. If you want hand-holding and a system, WW has an edge; if you want minimal friction and just the medication, Hims/Hers may suit you. None of them removes the need to qualify medically.
Noom vs WeightWatchers for GLP-1
Both pair medication with behavior change, but the philosophies differ. Noom is rooted in psychology and habit reframing, while WW uses its points framework and community model. For GLP-1 specifically, brand medication is the same drug wherever you get it, so your choice comes down to price and to which coaching style you will actually use month after month. As of September 5, 2026, Noom's brand-medication track is $39 for the first month and then $129 a month, and WW Med+ is $25 a month for two months and then $74, with medication extra in both. Noom also sells compounded semaglutide ($129 then $249), a microdose semaglutide track ($79 then $179) and compounded tirzepatide ($149 then $299), none of which WW offers.
How to choose a GLP-1 program
Focus on four things: whether a licensed clinician evaluates you, whether the pharmacy is properly licensed, the all-in monthly cost (membership plus medication), and how easy it is to cancel. If weight loss is your goal and you want to compare medication-first options on price and clinical oversight, FormBlends' provider comparison tool lets you line up vetted GLP-1 providers side by side, and our compounded semaglutide page explains how supervised programs are structured.
What WeightWatchers GLP-1 (Med+) costs in September 2026
WW splits the bill into a membership and the medication, and its own pages answer the price question that most searches for this page are asking. Figures below were read from weightwatchers.com on September 5, 2026 and from the manufacturers' self-pay pages on September 4, 2026.
| Line item | Price | Notes |
|---|---|---|
| Med+ membership | $25 a month for the first two months on a 12-month plan, then $74 a month | Offer ends September 8, 2026 at 11:59 PM PDT; medication not included |
| GLP-1 Success (no-prescription track) | Advertised at $20 a month, limited offer | For people already on a GLP-1 from another prescriber |
| Zepbound, cash pay via LillyDirect | $299 (2.5 mg), $399 (5 mg), $449 (7.5 to 15 mg) | Vial or KwikPen; $599 to $1,049 if a refill is delayed; WW states the KwikPen is not eligible for insurance coverage |
| Wegovy pen, cash pay | $199 for the first two fills (new patients, through December 31, 2026), then $349; 7.2 mg $399 | wegovy.com self-pay pricing |
| Wegovy pill, cash pay | $149, $199 or $299 by dose | wegovy.com |
| Any medication with commercial insurance | Your plan's copay | WW's insurance coordinators work with commercial plans only, not Medicare, Medicaid or Kaiser |
| Medicare beneficiaries | $50 a month via the Medicare GLP-1 Bridge | July 1, 2026 to December 31, 2027; Zepbound KwikPen, Wegovy pen and pill, Foundayo; prior authorization; separate from WW |
All in, a cash-pay member on the starting dose of Zepbound is paying $324 a month for the first two months and $373 after that; on Wegovy's introductory pen price, $224 then $423. Those are the numbers to compare against Noom, Hims and the compounded market below.
Brand-only: WW does not sell compounded GLP-1s, and what that means for price
Every medication on WW's September 2026 menu is FDA-approved: Wegovy injection and pill, Zepbound, Saxenda, Foundayo, metformin and naltrexone/bupropion. No compounded semaglutide or tirzepatide appears on any WW page, and third-party reviewers date the compounded exit to May 2025, a few months after the FDA declared the tirzepatide (December 19, 2024) and semaglutide (February 21, 2025) shortages resolved.
That is a safety choice with a price. The FDA had logged 990 adverse-event reports for compounded semaglutide and more than 730 for compounded tirzepatide as of May 31, 2026, which is the case for brand. On the other side, compounded semaglutide had a month-1 median price of $197 and compounded tirzepatide $299 across the 14 providers in the Compounded GLP-1 Price Index on September 3, 2026, against $199 to $349 for the Wegovy pen and $299 to $449 for Zepbound before any membership fee. Noom sells compounded tirzepatide at $149 for the first month and $299 after. For FormBlends' own compounded products, the current price is on the product page and in the index. If you want compounded, WW is not the program; if you want brand with coaching, it is one of the cheaper memberships.
WeightWatchers GLP-1 reviews and results: the numbers that exist
Most review content about WW's GLP-1 program is anecdote. These are the figures with a source and a date, as of September 5, 2026, with the caveat that the first two are the company's own.
| Figure | Value | Source |
|---|---|---|
| Average body-weight loss at 12 months, Med+ members on a GLP-1 | 21% | WW company data, about 3,250 patients, not peer reviewed (weightwatchers.com) |
| Med+ members who say the program helps minimize side effects | More than 70% | WW member survey, cited in its December 16, 2025 release |
| GLP-1 users who want community support | 90% | WW-commissioned survey, same release |
| Trustpilot rating | About 3.9 out of 5 across more than 1,660 reviews | As reported by third-party review sites, September 2026 |
| Trial benchmark | 20.9% mean weight loss at 72 weeks on Zepbound 15 mg; 15.0% at 5 mg | Zepbound prescribing information, SURMOUNT-1 |
The 21% figure is plausible because it matches what the drug does in trials; it is not evidence that WW's coaching adds to the drug, since there is no comparison group. The recurring complaint themes in member reviews are the ones this article already lists: billing that is easier to start than stop, wait times, and a wanted medication not being covered. We have not reproduced individual reviews.
Noom vs WeightWatchers vs Hims for GLP-1s: September 2026 price table
The three programs this page compares publish very different price structures. Noom's and WW's were read from their own sites on September 5, 2026. Hims' pages returned an access error to our fetch, so its figures come from a July 2026 third-party review (Mira Health) and should be verified on hims.com before you rely on them.
| Program | Membership | Medication | Compounded GLP-1s? |
|---|---|---|---|
| WeightWatchers Med+ | $25 a month for two months, then $74 | Brand only, billed separately: Zepbound $299 to $449 via LillyDirect; Wegovy pen $199 then $349; Wegovy pill $149 to $299 | No |
| Noom Med | Brand-med track $39 first month then $129; compounded tracks priced as medication plus program | Compounded semaglutide $129 then $249 a month; microdose semaglutide $79 then $179; compounded tirzepatide $149 then $299; metformin $69 then $99; all billed quarterly | Yes |
| Hims and Hers (second-hand) | $39 first month, then $149 a month | Wegovy pill $149, Wegovy pen $199, Zepbound $299 | Compounded semaglutide closed to new patients March 9, 2026 after a settlement with Novo Nordisk, per the same review |
| Ro (for comparison) | From $74 a month on annual prepay | Zepbound KwikPen $299 to $449 | Not on its Zepbound page |
Read across a row and the pattern is that brand Zepbound costs $299 for the starting dose everywhere, because every program resolves to Lilly's self-pay tiers; the difference is the fee on top. Noom's Aug 14, 2026 comparison post makes the same point from its side, and adds that only 19% of large employers covered weight-loss GLP-1s in 2025 (KFF), so most members in all three programs are paying cash for the drug.
Is WeightWatchers still in business? The 2025 bankruptcy and the December 2025 relaunch
Yes. WW International filed a prepackaged Chapter 11 case in Delaware on May 6, 2025, kept operating throughout, had its plan confirmed on June 17, 2025 and emerged on June 24, 2025 as a private company with about $1.15 billion of debt eliminated (Simpson Thacher, June 25, 2025; CNN, May 6, 2025). Members' subscriptions and the clinical program continued without interruption.
On December 16, 2025 the company relaunched its platform around GLP-1 users under CEO Tara Comonte and chief medical officer Dr. Kim Boyd, with Med+ (the prescribing track), GLP-1 Success (support for people already on a GLP-1), a Weight Health Score, an AI body scanner and a strength-focused fitness program. The pricing and medication menu on this page are from that post-relaunch program. If you enrolled before mid-2025 and are comparing your old plan to what is on the site now, assume the terms have changed.
FAQ
Can you get GLP-1 through WeightWatchers?
Yes. WW's clinical telehealth arm can prescribe GLP-1 medications to eligible members and pairs them with behavioral coaching.
Is WeightWatchers GLP-1 safe?
It is a legitimate, clinician-supervised program with a prescription requirement and medical screening. The main cautions are membership costs and cancellation terms, not safety.
How much does WeightWatchers GLP-1 cost?
As of September 5, 2026, Med+ is $25 a month for the first two months on a 12-month plan, then $74 a month (offer ends September 8, 2026); medication is billed separately. Cash-pay Zepbound through LillyDirect is $299, $399 or $449 a month by dose, Wegovy's pen is $199 for the first two fills then $349, and the Wegovy pill is $149 to $299. With insurance, you pay your plan's copay.
Hims vs WeightWatchers, which is better for GLP-1?
Hims is faster and lighter-touch; WeightWatchers offers deeper behavioral support. Both require medical qualification.
Is Noom or WeightWatchers better with a GLP-1?
The brand medication is identical; choose on price and coaching style. Noom's brand-med track is $39 then $129 a month and WW Med+ is $25 then $74 (September 5, 2026), medication extra in both; Noom is psychology-led and also sells compounded GLP-1s, WW is points-and-community and brand-only.
Does WeightWatchers offer compounded or branded GLP-1s?
Brand only, as of September 5, 2026: Wegovy injection and pill, Zepbound, Saxenda, Foundayo, metformin and naltrexone/bupropion. WW offered compounded semaglutide until May 2025 according to third-party reviews and no longer lists any compounded GLP-1.
Do I still need to qualify medically?
Yes. Every legitimate program screens you on BMI and health history before prescribing.
Is GLP-1 the same as a specific drug?
No. GLP-1 is a drug class that includes semaglutide, tirzepatide, and others, not one single medication.
Does WeightWatchers work with insurance for GLP-1s?
Partly. WW's insurance coordinators handle prior authorizations and refills for commercial plans only; the company states they cannot work with government plans (Medicare, Medicaid) or Kaiser (weightwatchers.com, September 5, 2026). With coverage you pay your plan's copay for the drug plus the $74 Med+ membership. Without coverage you pay LillyDirect or Wegovy self-pay prices, and WW notes the Zepbound KwikPen is not eligible for insurance at all.
Is WeightWatchers still in business in 2026?
Yes. WW International filed a prepackaged Chapter 11 on May 6, 2025, kept operating, and emerged as a private company on June 24, 2025 with about $1.15 billion of debt eliminated. It relaunched its platform on December 16, 2025 around GLP-1 users, with Med+ prescribing, a no-prescription GLP-1 Success track and new tools, under CEO Tara Comonte. The prices and medication menu on this page are from the relaunched program.
Can I use the Medicare GLP-1 Bridge through WeightWatchers?
Not through WW's insurance coordinators, who work with commercial plans only. The Medicare GLP-1 Bridge runs from July 1, 2026 to December 31, 2027 and prices the Zepbound KwikPen, Wegovy pen and pill, and Foundayo at $50 a month for eligible beneficiaries with prior authorization, outside the $2,100 Part D cap (healthinsurance.org). A Medicare beneficiary could join WW's $20 GLP-1 Success track for coaching while getting the drug through the Bridge from their own prescriber.
Related guides
- Semaglutide vs Phentermine: New vs Old School Weight Loss
- Glp-1 vs Weight Watchers Which Works Better
- Hims vs Calibrate for Weight Loss: GLP-1 Telehealth Programs Compared
- In-Person Weight Loss Clinic vs Online Telehealth GLP-1
- Glp 1 Single Dose Vials New Option
- TrueBody vs Hims for GLP-1: New vs Established Platform
Sources
- WeightWatchers Med+ prescription weight-loss medication page, seen September 5, 2026: https://www.weightwatchers.com/us/weight-loss-medication
- FDA. FDA's concerns with unapproved GLP-1 drugs used for weight loss (semaglutide shortage resolved February 21, 2025): https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
- Hims & Hers weight loss program: https://www.hims.com/weight-loss
- WeightWatchers. Online prescription weight-loss medication (Med+), seen September 5, 2026. https://www.weightwatchers.com/us/weight-loss-medication
- WeightWatchers. GLP-1 Success program, seen September 5, 2026. https://www.weightwatchers.com/us/how-it-works/glp-1-program
- WeightWatchers. Zepbound through Med+, seen September 5, 2026. https://www.weightwatchers.com/us/weight-loss-medication/zepbound
- WW International. Weight Watchers launches a fully integrated platform for the GLP-1 era, December 16, 2025 (corporate.ww.com news release; bot-walled to our fetch on September 5, 2026).
- Simpson Thacher. WeightWatchers completes financial reorganization following Chapter 11 plan approval, June 25, 2025. https://www.stblaw.com/about-us/news/view/2025/06/25/weightwatchers-completes-financial-reorganization-following-chapter-11-plan-approval
- CNN. Weight Watchers files for bankruptcy, May 6, 2025. https://www.cnn.com/2025/05/06/business/weight-watchers-bankruptcy
- Noom Med. Pricing, seen September 5, 2026. https://www.noom.com/med/pricing/
- Noom. Noom vs Weight Watchers, updated August 14, 2026. https://www.noom.com/blog/weight-management/noom-vs-weight-watchers/
- Mira Health. Hims and Hers GLP-1 weight loss programs review, July 2026 (second-hand for Hims pricing; hims.com returned an access error on September 5, 2026).
- WeightRx Guide. WeightWatchers Clinic GLP-1 review (Trustpilot aggregate, compounded exit date), seen September 5, 2026. https://weightrxguide.com/reviews/weightwatchers-clinic-glp1-review
- Novo Nordisk. What to pay for Wegovy, seen September 4, 2026. https://www.wegovy.com/obesity/what-to-pay-for-wegovy.html
- Eli Lilly. LillyDirect Zepbound self-pay pricing, seen September 4, 2026. https://www.lilly.com/lillydirect/zepbound
- Eli Lilly. Zepbound prescribing information, revised 08/2026 (SURMOUNT-1 weight-loss results). https://pi.lilly.com/us/zepbound-uspi.pdf
- healthinsurance.org. Does health insurance cover drugs used for weight loss? Seen September 4, 2026. https://www.healthinsurance.org/faqs/does-health-insurance-cover-drugs-used-for-weight-loss-such-as-ozempic-wegovy-mounjaro-and-zepbound/
- KFF. 2025 Employer Health Benefits Survey, October 22, 2025. https://www.kff.org/health-costs/2025-employer-health-benefits-survey/
- FDA. Tirzepatide injection shortage resolved, December 19, 2024. https://www.fda.gov/media/185577/download
- FormBlends. Compounded GLP-1 Price Index feed, as of September 3, 2026. https://formblends.com/feeds/glp1-prices.json
See your options in about 2 minutes
Take the free quiz and see what fits you. Quick, private, and no commitment to continue.
See my options →